Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 35, 2006 - Issue 4
Submit an article Journal homepage
130
Views
22
CrossRef citations to date
0
Altmetric
CASE REPORT

The effect of TNFα blockade in complicated, refractory Kawasaki disease

E. V. Stenbøg Departments of PaediatricsCorrespondence[email protected]
,
B. Windelborg Departments of Paediatrics
,
A. Hørlyck Radiology, Aarhus University Hospital, Section SKS, AarhusDenmark
&
T. Herlin Departments of Paediatrics
Pages 318-321 | Received 18 Jul 2004, Accepted 20 Jan 2006, Published online: 12 Jul 2009

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Marian Chan & Raashid Luqmani. (2009) Pharmacotherapy of vasculitis. Expert Opinion on Pharmacotherapy 10:8, pages 1273-1289.
Read now
T. Hoshina, K. Kusuhara, K. Ikeda, Y. Mizuno, M. Saito & T. Hara. (2008) High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease. Scandinavian Journal of Rheumatology 37:6, pages 445-449.
Read now

Articles from other publishers (20)

Lihe Wang, Milan He, Wei Wang, Shiya Li & Guoxiao Zhao. (2024) Efficacy and safety of infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis. European Journal of Pediatrics 183:4, pages 1765-1776.
Crossref
Suad Kabbaha, Alyssa Milano, Mamoon A. Aldeyab & Kristian Thorlund. (2022) Infliximab as a second‐line therapy for children with refractory Kawasaki disease: A systematic review and meta‐analysis of randomized controlled trials. British Journal of Clinical Pharmacology 89:1, pages 49-60.
Crossref
Xuan Li, Yunjia Tang, Yueyue Ding, Ye Chen, Miao Hou, Ling Sun, Guanghui Qian, Liqiang Qin & Haitao Lv. (2021) Higher efficacy of infliximab than immunoglobulin on Kawasaki disease, a meta-analysis. European Journal of Pharmacology 899, pages 173985.
Crossref
Alessandra Marchesi, Isabella Tarissi de Jacobis, Donato Rigante, Alessandro Rimini, Walter Malorni, Giovanni Corsello, Grazia Bossi, Sabrina Buonuomo, Fabio Cardinale, Elisabetta Cortis, Fabrizio De Benedetti, Andrea De Zorzi, Marzia Duse, Domenico Del Principe, Rosa Maria Dellepiane, Livio D’Isanto, Maya El Hachem, Susanna Esposito, Fernanda Falcini, Ugo Giordano, Maria Cristina Maggio, Savina Mannarino, Gianluigi Marseglia, Silvana Martino, Giulia Marucci, Rossella Massaro, Christian Pescosolido, Donatella Pietraforte, Maria Cristina Pietrogrande, Patrizia Salice, Aurelio Secinaro, Elisabetta Straface & Alberto Villani. (2018) Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks. Italian Journal of Pediatrics 44:1.
Crossref
Nikita Lakdawala & Flavia Fedeles. (2017) Vasculitis: Kids are not just little people. Clinics in Dermatology 35:6, pages 530-540.
Crossref
. (2014) Guidelines for medical treatment of acute K awasaki disease: Report of the R esearch C ommittee of the J apanese S ociety of P ediatric C ardiology and C ardiac S urgery (2012 revised version) . Pediatrics International 56:2, pages 135-158.
Crossref
Stephanie Bayers, Stanford T. Shulman & Amy S. Paller. (2013) Kawasaki disease. Journal of the American Academy of Dermatology 69:4, pages 513.e1-513.e8.
Crossref
Rosie Scuccimarri. (2012) Kawasaki Disease. Pediatric Clinics of North America 59:2, pages 425-445.
Crossref
Rae S. M. Yeung. 2012. Textbook of Clinical Pediatrics. Textbook of Clinical Pediatrics 1675 1684 .
Mariano Arturo Díaz-Orta & Jorge Rojas-Serrano. (2011) Terapia biológica en las vasculitis sistémicas. Reumatología Clínica 7, pages 33-36.
Crossref
J. Salas Salguero, D. Gómez-Pastrana Durán, C. Salido Peracaula, C. Ruiz-Berdejo Iznardi & J. Ortiz Tardío. (2010) Enfermedad de Kawasaki refractaria con aneurismas coronarios tratada con infliximab. Anales de Pediatría 73:5, pages 268-271.
Crossref
Robert J Brogan, Despina Eleftheriou, James Gnanapragasam, Nigel J Klein & Paul A Brogan. (2009) Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report. Pediatric Rheumatology 7:1.
Crossref
Mary Beth F. Son, Kimberlee Gauvreau, Lin Ma, Annette L. Baker, Robert P. Sundel, David R. Fulton & Jane W. Newburger. (2009) Treatment of Kawasaki Disease: Analysis of 27 US Pediatric Hospitals From 2001 to 2006. Pediatrics 124:1, pages 1-8.
Crossref
Jane C. Burns, Brookie M. Best, Asuncion Mejias, Lynn Mahony, David E. Fixler, Hasan S. Jafri, Marian E. Melish, Mary Anne Jackson, Basim I. Asmar, David J. Lang, James D. Connor, Edmund V. Capparelli, Monica L. Keen, Khalid Mamun, Gregory F. Keenan & Octavio Ramilo. (2008) Infliximab Treatment of Intravenous Immunoglobulin–Resistant Kawasaki Disease. The Journal of Pediatrics 153:6, pages 833-838.e6.
Crossref
Carol A Langford. (2008) Drug Insight: anti-tumor necrosis factor therapies for the vasculitic diseases. Nature Clinical Practice Rheumatology 4:7, pages 364-370.
Crossref
Rolando Cimaz & Anne Marie Prieur. (2008) Advances in pediatric rheumatology. Future Rheumatology 3:3, pages 239-251.
Crossref
B. Díaz-Ley, G. Guhl & J. Fernández-Herrera. (2007) Uso de fármacos biológicos en dermatosis fuera de la indicación aprobada. Primera parte: infliximab y adalimumab. Actas Dermo-Sifiliográficas 98:10, pages 657-678.
Crossref
Paul A. Brogan. (2007) What’s new in the aetiopathogenesis of vasculitis?. Pediatric Nephrology 22:8, pages 1083-1094.
Crossref
B. Díaz-Ley, G. Guhl & J. Fernández-Herrera. (2007) Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 1: Infliximab and Adalimumab. Actas Dermo-Sifiliográficas (English Edition) 98:10, pages 657-678.
Crossref
Fernanda Falcini & Rolando Cimaz. 2007. Pediatrics in Systemic Autoimmune Diseases. Pediatrics in Systemic Autoimmune Diseases 137 283 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.